Screener
Omnicell OMCL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Omnicell in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Omnicell’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000926326-26-000022
FAQ
- What is Omnicell's cash & equivalents?
- Omnicell (OMCL) reported cash & equivalents of $322.75M in Q2 2026.
- How has Omnicell's cash & equivalents changed year-over-year?
- Omnicell's cash & equivalents decreased by 25.2% year-over-year, from $431.5M to $322.75M.
- What is the long-term trend for Omnicell's cash & equivalents?
- Over 5 years (2020 to 2025), Omnicell's cash & equivalents has grown at a -12.5% compound annual growth rate (CAGR), from $489.92M to $251.03M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Omnicell's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude